News: WellPoint Inc (WLP)

WLP on New York Consolidated

113.51USD
25 Jul 2014
Price Change (% chg)

$-1.74 (-1.51%)
Prev Close
$115.25
Open
$113.52
Day's High
$114.23
Day's Low
$111.12
Volume
1,984,010
Avg. Vol
1,836,317
52-wk High
$116.26
52-wk Low
$81.46

Search Stocks
Select another date:

Thu, May 1 2014

UPDATE 2-Cigna says early Obamacare enrollee costs are high

May 1 - U.S. health insurer Cigna Corp on Thursday said that early enrollees in new plans created under President Barack Obama's healthcare law used medical services more than it expected, confirming early forecasts it would lose money on the business in 2014.

WellPoint's Obamacare business making a profit, so far

- WellPoint Inc on Wednesday said that its Obamacare exchange business was sustainable so far, echoing comments from another major insurer last week that these new customers have cost as much as expected, not more.

UPDATE 3-WellPoint's Obamacare business making a profit, so far

April 30 - WellPoint Inc on Wednesday said that its Obamacare exchange business was sustainable so far, echoing comments from another major insurer last week that these new customers have cost as much as expected, not more.

WellPoint says hepatitis C drugs Q1 cost was $50 mln

April 30 - WellPoint Inc said on Wednesday during a conference call that it had spent $50 million on hepatitis C drugs during the first quarter.

WellPoint CEO says to add more than 600,000 exchange customers

- WellPoint Inc. Chief Executive Officer Joseph Swedish said on Wednesday that the company expects to add more than 600,000 new members through the individual health insurance exchanges this year created under President Barack Obama's healthcare reform law.

WellPoint CEO says to add more than 600,000 exchange customers

April 30 - WellPoint Inc. Chief Executive Officer Joseph Swedish said on Wednesday that the company expects to add more than 600,000 new members through the individual health insurance exchanges this year created under President Barack Obama's healthcare reform law.

WellPoint says first-quarter profit fell on reform costs

- WellPoint Inc , the second-largest U.S. health insurer, said on Wednesday that first-quarter profit fell, largely because of investment spending related to healthcare reform and the higher administrative costs of adding new commercial customers.

WellPoint says first-quarter profit fell on reform costs

April 30 - WellPoint Inc, the second-largest U.S. health insurer, said on Wednesday that first-quarter profit fell, largely because of investment spending related to healthcare reform and the higher administrative costs of adding new commercial customers.

WellPoint says new hepatitis c drug prices are too high

- The head of WellPoint Inc's commercial business said on Friday that the price of new hepatitis c drugs, which are made by Gilead Sciences Inc and Johnson and Johnson, are too high.

WellPoint says new hepatitis c drug prices are too high

March 21 - The head of WellPoint Inc's commercial business said on Friday that the price of new hepatitis c drugs, which are made by Gilead Sciences Inc and Johnson and Johnson, are too high.

Select another date:
Search Stocks